browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
8a827c50-1c77-4e1e-9570-21524aba2370
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 22:40:47
Income (reported)
—
Expenses (reported)
$190,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

AMNEAL PHARMACEUTICALS

Contact
JULIAN MALASI
Phone
+1 843-330-9995
Address
zip:08807, city:Bridgewater, state:NJ, street:400 Crossing Boulevard 3rd Floor
Client

AMNEAL PHARMACEUTICALS

Pharmaceutical company

State
NJ
Country
US
Effective date
2024-01-01
Issues lobbied + lobbyists (1)

HCR — Health Issues

Addressing drug shortages and enhancing domestic production of critical medicines Issues and proposed legislation related to long-term sustainability of access for patients to generic and biosimilar medicines, including but not limited to pharmaceutical supply chain security, drug shortages, biosimilar interchangeability, and PBM reform Issues related to Medicaid Generics Penalty Issues related to possible drug shortage of levothyroxine capsules Issues related to tariffs Appropriations for increasing domestic manufacturing of generic medicines Issues related to NDAA

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE; White House Office

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.